Challenges with antimicrobial susceptibility testing for Neisseria gonorrhoeae in the era of extensively drug-resistant gonorrhoea - molecular antimicrobial resistance testing crucial

Comment

Magnus Unemo. Pathog Glob Health. 2014 Jul.

. 2014 Jul;108(5):214-5.

doi: 10.1179/2047772414Z.000000000216.

No abstract available

Comment on

Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
Endimiani A, Guilarte YN, Tinguely R, Hirzberger L, Selvini S, Lupo A, Hauser C, Furrer H. Endimiani A, et al. BMC Infect Dis. 2014 Feb 25;14:106. doi: 10.1186/1471-2334-14-106. BMC Infect Dis. 2014. PMID: 24568221 Free PMC article.

1. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012;7:1401–22. - PMC - PubMed
1. Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century – past, evolution and future. Clin Microbiol Rev. 2014;27:587–613. - PMC - PubMed
1. World Health Organization (WHO) Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae Geneva: WHO; 2012. p.1–36.
1. Endimiani A, Guilarte YN, Tinguely R, Hirzberger L, Selvini S, Lupo A, et al. Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998–2012): emergence of multidrug-resistant clones less susceptible to cephalosporins. BMC Infect Dis. 2014;14:106. - PMC - PubMed
1. Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7:821–34. - PubMed